8 Virtual Care and Telemedicine Companies for Clinical Trials in 2026

A telemedicine clinical trials provider lets a study visit happen over video or through a coordinated remote care model instead of requiring a patient to travel to a physical site, which can widen who is able to participate and reduce the burden of a multi-visit protocol. This kind of vendor ranges from purpose-built video and workflow platforms designed specifically for the regulatory and consent requirements of clinical research, to clinical trial site organizations that blend home visits, mobile research units, and virtual check-ins into a single coordinated delivery model.

The virtual care and telemedicine companies below are listed in no particular order. Between them, these companies and providers cover purpose-built clinical trial video visit platforms, behavioral-science-driven patient engagement apps, virtual investigator meeting technology, and hybrid site organizations that combine in-clinic, home, and virtual visits.

Consilx Digital

Consilx Digital operates a modular technology suite for decentralized clinical trials built around five platforms: eConsent, Patient Engagement, Direct Data Collection, Telemedicine, and LifeLedger, a blockchain-based system for managing a trial's entire conduct. The company's Telemedicine Platform is purpose-built for clinical research, enabling multi-party video calling and text chat between patients and site personnel rather than adapting a general consumer telehealth tool. Consilx's client base includes Top-10 pharmaceutical companies, a global CRO consortium, and mid-tier CROs and research organizations, and the company differentiates its offering through blockchain-based architecture intended to ensure data integrity and traceability across every data and document exchange. The company also offers LifeLedger, which tracks a patient's full journey through a clinical trial with remote capabilities and real-time interactions.

Datacubed Health

Datacubed Health was founded in 2016 by Dr. Paul Glimcher, a neuroeconomics researcher and NYU Grossman School of Medicine professor, who built the company's ePRO app around behavioral science principles rather than a standard data-entry interface. The company reports its patient-facing app, which layers reward, motivation, and identity-based design elements onto routine clinical trial tasks, achieves patient compliance and retention rates above 90 percent. CEO Brett Kleger, who previously held operational and product roles at DrugDev, IQVIA, and Acurian, leads the company's day-to-day operations alongside Glimcher, who continues as Chairman and Chief Scientific Officer. A 2025 peer-reviewed study comparing Datacubed's mobile app against a website and paper-based data collection found the behavioral-science-driven app produced measurably higher participant adherence and retention over the course of the study.

Delve Health

Delve Health runs Clinical StudyPal, an end-to-end cloud platform supporting virtual, hybrid, and decentralized clinical trials that includes a proprietary TeleVisit feature alongside digital recruitment, eConsent, ePRO/eCOA, wearable device integration, and site-based data capture. Founded in 2015 by CEO Wessam Sonbol and Tamer Swidan, the Minneapolis-based company has supported more than 100 studies and 26 disease registries across therapeutic areas including oncology, cardiovascular, endocrinology, and pediatric disorders. Delve Health's platform is fully configurable, letting sponsors select only the specific components a given study needs rather than adopting a fixed, pre-packaged solution. The company has partnered with digital health testing provider cerascreen to combine at-home diagnostic testing with its broader decentralized trial platform.

Lightship

Lightship operates as a modern clinical trial site organization that runs studies in-clinic, at home, virtually, and through mobile research units under one coordinated team, an approach the company says increases participant enrollment more than twofold compared with traditional brick-and-mortar sites alone. Founded in 2018 and based in El Segundo, California, the company merged with Circuit Clinical in 2025 to expand its combined physical site network and remote delivery capabilities, and in February 2026 acquired Veda Trials, a community-based clinical research organization, to further extend its reach into specialty clinics for women's health, dermatology, and allergy and asthma. Lightship has raised more than $60 million across its funding history, including a $40 million round in 2021 backed by McKesson Ventures and Marc Benioff's TIME Ventures. The company reports that more than 40 percent of the patients it engages come from racially or ethnically diverse communities, and that studies using its expanded reach model activate roughly 40 percent faster than the industry average.

Medocity

Medocity, founded in 2013 as ICANCERHELP before rebranding, operates a configurable virtual care platform serving pharmaceutical companies, health insurers, and hospital systems, with a dedicated Digital Clinical Trials Solutions group supporting all phases of studies and patient support. The company's platform integrates AI-driven algorithms with real-time patient and clinical team interaction, and Medocity has been endorsed by Gartner in prior years for its user experience and ease-of-use ratings among patients and healthcare providers. In 2023, Medocity partnered with digital transformation company Globant to expand its REACH patient recruitment and enrollment offering, combining Medocity's real-world data and physician insight capabilities with Globant's omnichannel digital outreach technology to improve patient diversity in trial recruitment. Medocity's platform is used across multiple chronic and complex conditions, including gene therapy trials, and the company markets itself under the tagline “Virtual care. Real outcomes.”

MedPoint Digital

MedPoint Digital has run virtual investigator meetings for the biopharmaceutical industry since 1993, and the company says it has produced more than 1,500 virtual investigator meetings to date through its Elevation platform, which is built for ICH GCP compliance and rigorous data security standards. Based in Evanston, Illinois, the company expanded rapidly into web-based training, communications, and virtual meeting tools after the September 11 attacks curtailed business travel across the industry, and it has continued adding capabilities including a Live Immersive Virtual Environment and an AI tool for clinical trials. MedPoint's TriPort investigator trial portal centralizes site training tracking, documents, and reporting, while its InSite Virtual product supports remote monitoring of investigator sites. The company reports that more than half of its meeting attendees are located outside the US, and for two of its three largest clients, it serves more study teams in Europe than in the US.

ObvioHealth

ObvioHealth launched in 2017 as one of the first companies to describe itself as a Virtual Research Organization (VRO), and the company's core product, ObvioGo, is an enterprise digital platform combining study design tools, digital instruments, real-world data, and AI to support hybrid and fully decentralized clinical trials. Founded and led by CEO Ivan Jarry, the New York-based company released ObvioGo 2.0 in April 2024, adding the ability to mix hybrid and virtual trial designs with tailored workflows, languages, and documents across as many as 20 different sites within a single study. ObvioHealth's platform has since added enhanced assent and counter-signature eConsent capabilities designed to support studies involving minors or participants unable to provide legal consent on their own. The company positions its combination of deep clinical science expertise and purpose-built digital tools as a differentiator from platforms that were originally built for other industries and later adapted for clinical trials.

TrialX

TrialX launched the first clinical trials app on Google Health in 2008, and the company has since built two core platforms: TrialX Connect, an award-winning patient recruitment management system, and TrialX Advance, a fully scalable end-to-end platform for hybrid and virtual global clinical trials that includes eConsent, eCOA/ePRO, wearable integrations, and virtual visits alongside a dedicated analytics dashboard. Based in Tarrytown, New York, the company has supported more than 444 studies and hosts over 40,000 trial listings through its recruitment platform, which serves pharmaceutical sponsors, academic medical centers, and patient advocacy groups. TrialX added a Diversity, Equity, and Inclusion toolkit to its Connect platform, aimed at bringing greater representation into patient recruitment workflows across the studies it supports. Beyond terrestrial clinical trials, the company has also worked on research data collection technology for commercial space missions, positioning itself as a clinical research and space health informatics company.

Explore the full Telemedicine landscape

The companies above represent a portion of a much larger field.

Diligent's platform includes over 195 Telemedicine Vendors, many with Vendor qualification data available on demand. Book a demo to explore Diligent's full vendor discovery database.

This article is intended as an informational overview of vendors operating in this space. Inclusion on this list does not constitute an endorsement, recommendation, or qualification by Diligent.